Save time and get answers to complex questions with AI chat
Zemdri nce gain exclusivity 2028 patent 2031?Bivalirudin manufacturer?Is guselkumab off patent in u s?When is tenofovir alafenamide patent expiring?Combivent inhaler hfc 152a patents?
See the DrugPatentWatch profile for Orilissa
Orilissa (elagolix) is a prescription medicine taken by mouth. Its active ingredient is elagolix; the rest of the formulation consists of inactive ingredients (excipients) that help the tablet work and stay stable.
The active ingredient in Orilissa is elagolix. The inactive ingredients depend on the exact Orilissa tablet strength and formulation used (the label can list different excipients by strength and brand packaging).
Because inactive ingredients can vary by tablet strength, the most accurate source is the package insert or the “Inactive ingredients” section of the FDA-approved prescribing information for your specific Orilissa dosage (and whether you have the 150 mg or 200 mg tablets, as applicable). If you tell me the strength on your bottle (150 mg or 200 mg) and whether it’s tablets, I can help you pinpoint what to look for on the label.
Other Questions About Orilissa :